We have clarified in the murine study that CD8+ CTL EVs prevent tumour metastasis by modulating mesenchymal cell populations in the primary tumor lesions via their content, such as miR‐298‐5p (Seo et al., 2018). The gene discussed is CD8A; the disease is neoplasm.